Pirfenidone-Induced Sarcoid-Like Reaction A Novel Complication

被引：0
|
作者：
Kolaitis, Nicholas A. [1 ]
Kukreja, Jasleen [2 ]
Jones, Kirk D. [3 ]
Hays, Steven R. [1 ]
Leard, Lorriana E. [1 ]
机构：
[1] Univ Calif San Francisco, Sch Med, Dept Med, San Francisco, CA 94143 USA
[2] Univ Calif San Francisco, Sch Med, Dept Surg, San Francisco, CA 94143 USA
[3] Univ Calif San Francisco, Sch Med, Dept Pathol, San Francisco, CA 94143 USA
来源：
CHEST | 2018年 / 154卷 / 04期
关键词：
drug toxicity; idiopathic pulmonary fibrosis; lung transplant; pirfenidone (Esbrit); sarcoid-like reaction; IDIOPATHIC PULMONARY-FIBROSIS; MELANOMA;
D O I：
10.1016/j.chest.2018.03.048
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
Idiopathic pulmonary fibrosis is the most common idiopathic interstitial pneumonia. Prognosis is poor with a median survival <3 years. Pirfenidone is one of two US Food and Drug Administration-approved medications that slow disease progression. We describe the development of lymphadenopathy or a sarcoid-like reaction following initiation of pirfenidone, a complication not previously reported.
引用
收藏
页码：E89 / E92
页数：4
相关论文
共 50 条
12345